Oncology PracticeFDA approves PARP inhibitor for BRCA+ advanced breast cancerJanuary 12, 2018Breast Cancer
Oncology PracticePain after breast surgery may not be caused by the operationJanuary 10, 2018Breast CancerPatient & Survivor Care
Oncology PracticeModeling study: Screening, treatment effects on breast cancer mortality vary by subtypeJanuary 9, 2018Breast Cancer
Oncology PracticeTrial updates will help tailor endocrine therapy for premenopausal breast cancerJanuary 3, 2018Breast CancerPatient & Survivor Care
Oncology PracticeNew tool predicts late distant recurrence of postmenopausal ER+ breast cancerJanuary 2, 2018Breast Cancer
Oncology PracticeEndoPredict results reflected tumor response to neoadjuvant therapyJanuary 2, 2018Breast Cancer
Oncology PracticeWider margins may reduce recurrence risk in early breast cancerJanuary 2, 2018Breast Cancer
Oncology PracticeEnzalutamide plus exemestane improves PFS in HR+ breast cancer subsetJanuary 2, 2018Breast Cancer
Oncology PracticeLapatinib plus trastuzumab improves outcomes in HER2+ breast cancerDecember 27, 2017Breast Cancer
Oncology PracticeAxillary node dissection can be avoided with limited SLN involvementDecember 26, 2017Breast Cancer
Oncology PracticeDCIS risk signature is validated in SweDCIS populationDecember 26, 2017Breast Cancer
Oncology PracticePath CR signals good outcomes in treated high-risk breast cancersDecember 21, 2017Breast Cancer
Oncology PracticePostmenopausal women who shed pounds see lower breast cancer riskDecember 18, 2017Breast CancerPreventive Care
